NLRP3 and lymphoma: Specific attention has been paid to the characterization of the NLRP3 inflammasome axis that seems to identify patients with a more severe disease at a greater risk for lymphomas.23 To classify pSS, MSGB is required in patients with a negative anti-SSA/Ro.